US Patent 10533045 Antibody purification and purity monitoring
Patent 10533045 was granted and assigned to Alder Biopharmaceuticals on January, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 21, 2016
Date of Patent
January 14, 2020
Patent Application Number
15331241
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10533045 Antibody purification and purity monitoring
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
